Search results
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow
Motley Fool via Yahoo Finance· 10 hours agoThe 10 stocks that made the cut could produce monster returns in the coming years. Consider when...
California Senate passes drug pricing transparency, could slash health costs
The Center Square· 5 days agoMarket-focused economists argue these groups engage in monopolistic practices that limit consumer...
Japan Exchange's Leading Growth Companies With High Insider Ownership In May 2024
Simply Wall St. via Yahoo Finance· 4 hours agoAs of May 2024, the Japanese market has shown resilience with a slight decline in major indices,...
Ozempic Patients Are Switching to These Less Expensive Weight-Loss Drugs — Best Life
Best Life· 3 days agoThe semaglutide injection is approved to treat Type 2 diabetes, but its off-label use as a chronic...
Clean needles save lives. In some states, they might not be legal.
Philly.com· 15 hours agoKim Botteicher hardly thinks of herself as a criminal. On the main floor of a former Catholic church...
An obscure drug discount program stifles use of federal lifeline by rural hospitals
Kansas Reflector via Yahoo News· 8 hours agoFacing ongoing concerns about rural hospital closures, Capitol Hill lawmakers have introduced a...
Senators blame sky-high drug prices on abuse of the patent system
NBC NEWS· 5 days agoThe drug industry’s top lobbying group on Tuesday faced fierce questioning at a Senate Judiciary...
Congress evaluates how to lower prescription prices by increasing competition
KIRO via Yahoo News· 5 days agoMedical experts say competition is key. They say big pharma has a limited period to sell a new drug...
Congress evaluates how to lower prescription prices by increasing competition
WHIO via Yahoo News· 5 days agoMedical experts say competition is key. They say big pharma has a limited period to sell a new drug...
5 Small Drug Stocks to Buy From a Recovering Industry
Zacks· 3 days agoConcerns around the economy and inflation, regular pipeline setbacks, uncertainty about the impact of Medicare drug price negotiations and the Federal Trade Commission’s scrutiny ...